LUND, Sweden, March 12, 2024 /PRNewswire/ — Immunovia (IMMNOV: Nasdaq) (IMMNOV: Stockholm), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, updates its financial calendar for 2024.
Annual Report to be published
April 25, 2024
Q1 Report, 2024
April 25, 2024
Annual General Meeting
June 4, 2024